- Home
- GCV vs ANIX Comparison
GCV vs ANIX Comparison
Compare GCV & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCV
- ANIX
- Stock Information
- Founded
- GCV 1988
- ANIX 1982
- Country
- GCV United States
- ANIX United States
- Employees
- GCV N/A
- ANIX N/A
- Industry
- GCV Finance/Investors Services
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- GCV Finance
- ANIX Health Care
- Exchange
- GCV Nasdaq
- ANIX Nasdaq
- Market Cap
- GCV 75.6M
- ANIX 84.7M
- IPO Year
- GCV N/A
- ANIX 1987
- Fundamental
- Price
- GCV $3.36
- ANIX $2.72
- Analyst Decision
- GCV
- ANIX Strong Buy
- Analyst Count
- GCV 0
- ANIX 3
- Target Price
- GCV N/A
- ANIX $9.00
- AVG Volume (30 Days)
- GCV 57.9K
- ANIX 65.3K
- Earning Date
- GCV 01-01-0001
- ANIX 06-03-2025
- Dividend Yield
- GCV 13.04%
- ANIX N/A
- EPS Growth
- GCV N/A
- ANIX N/A
- EPS
- GCV N/A
- ANIX N/A
- Revenue
- GCV N/A
- ANIX N/A
- Revenue This Year
- GCV N/A
- ANIX N/A
- Revenue Next Year
- GCV N/A
- ANIX N/A
- P/E Ratio
- GCV N/A
- ANIX N/A
- Revenue Growth
- GCV N/A
- ANIX N/A
- 52 Week Low
- GCV $3.15
- ANIX $2.07
- 52 Week High
- GCV $4.58
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- GCV 34.90
- ANIX 47.34
- Support Level
- GCV $3.35
- ANIX $2.55
- Resistance Level
- GCV $3.59
- ANIX $2.88
- Average True Range (ATR)
- GCV 0.16
- ANIX 0.22
- MACD
- GCV -0.02
- ANIX 0.01
- Stochastic Oscillator
- GCV 46.05
- ANIX 60.94
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.